frohike's profile

Recent Activity

• 21:39: posted Interpretation of microarray data in cancer
• 21:39: posted Prediction of cancer outcome with microarrays: a multiple random validation strategy.

• 10:55: posted Computational cluster validation in post-genomic data analysis

• 11:02: posted Addressing the problems with life-science databases for traditional uses and systems biology
• 10:21: posted Derivation of stable microarray cancer-differentiating signatures using consensus scoring of multiple random sampling and gene-ranking consistency evaluation.
• 10:16: posted Signature Evaluation Tool (SET): a Java-based tool to evaluate and visualize the sample discrimination abilities of gene expression signatures
• 10:15: posted Merging microarray data from separate breast cancer studies provides a robust prognostic test

• 14:14: posted Integrating microarray and proteomics data to predict the response on cetuximab in patients with rectal cancer.
• 14:10: posted Integration of clinical and microarray data with kernel methods.
• 14:02: posted Aberrant CpG-island methylation has non-random and tumour-type-specific patterns.
• 13:57: posted Proteomic contributions to personalized cancer care.
• 13:55: posted Cancer biomarkers--an invitation to the table.
• 13:52: posted TAILORx: trial assigning individualized options for treatment (Rx).
• 13:49: posted Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care?
• 13:45: posted Gene-expression signatures in breast cancer.
• 13:45: posted Gene-expression signatures in breast cancer.
• 13:45: posted Gene-expression signatures in breast cancer.
• 13:44: posted Gene-expression signatures in breast cancer.
• 13:42: posted Predicting the clinical status of human breast cancer by using gene expression profiles
• 13:41: posted Gene-expression profiles predict survival of patients with lung adenocarcinoma
• 12:10: posted From patterns to pathways: gene expression data analysis comes of age.
• 12:02: posted Techniques for clustering gene expression data
• 12:00: posted Comparison of Methods for Image Analysis on cDNA Microarray Data
• 11:52: posted Significance analysis of microarrays applied to the ionizing radiation response.

• 09:55: posted MicroRNAs accurately identify cancer tissue origin.
• 09:55: posted Cancer biomarker profiling with microRNAs
• 09:50: posted Identification of functional modules using network topology and high-throughput data
• 09:47: posted Epigenomics: Detailed analysis
• 09:43: posted Moving AHEAD with an international human epigenome project
• 09:23: posted The impact of microRNAs on protein output
• 09:20: posted The cancer biomarker problem
• 08:59: posted Mining the plasma proteome for cancer biomarkers
• 08:56: posted Translating insights from the cancer genome into clinical practice

• 13:04: posted Unique microRNA molecular profiles in lung cancer diagnosis and prognosis.
• 13:03: posted Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues.
• 13:02: posted MicroRNA gene expression deregulation in human breast cancer.
• 13:01: posted MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias.
• 12:31: posted Clustering of gene hypermethylation associated with clinical risk groups in neuroblastoma.
• 12:29: posted Prognostic DNA methylation biomarkers in ovarian cancer.
• 12:26: posted Aberrant DNA methylation as a cancer-inducing mechanism.
• 12:22: posted Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma.
• 11:58: posted The power and the promise of DNA methylation markers.

• 16:13: posted Bayesian updating in causal probabilistic networks by local computations
• 16:05: posted Local Computations with Probabilities on Graphical Structures and Their Application to Expert Systems
• 15:07: posted Bayesian Data Analysis, Second Edition
• 14:49: posted An Introduction to the Bootstrap
• 11:04: posted Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancer.
• 11:03: posted Phase I-II trial of cetuximab, capecitabine, oxaliplatin, and radiotherapy as preoperative treatment in rectal cancer.
• 10:12: posted Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification.
• 10:10: posted How large a training set is needed to develop a classifier for microarray data?
• 10:09: posted Sample size planning for developing classifiers using high-dimensional DNA microarray data.
• 10:08: posted Sample size determination in microarray experiments for class comparison and prognostic classification

• 15:01: posted The Molecular Biology Database Collection: 2008 update
• 14:38: posted Seeded Bayesian Networks: constructing genetic networks from microarray data
• 14:37: posted Constructing disease-specific gene networks using pair-wise relevance metric: application to colon cancer identifies interleukin 8, desmin and enolase 1 as the central elements
• 11:11: posted A Gene Expression Network Model of Type 2 Diabetes Links Cell Cycle Regulation in Islets with Diabetes Susceptibility